[ad_1] Researchers at Temple University in Philadelphia have developed a molecule that could be used in new cancer treatments. This molecule acts on an epigenetic marker, CDK9, which inhibits the expression of …
Read More »[ad_1] Researchers at Temple University in Philadelphia have developed a molecule that could be used in new cancer treatments. This molecule acts on an epigenetic marker, CDK9, which inhibits the expression of …
Read More »